Frazier Life Sciences Management, L.P. Verona Pharma PLC Transaction History
Frazier Life Sciences Management, L.P.
- $1.67 Billion
- Q4 2024
A detailed history of Frazier Life Sciences Management, L.P. transactions in Verona Pharma PLC stock. As of the latest transaction made, Frazier Life Sciences Management, L.P. holds 3,383,950 shares of VRNA stock, worth $230 Million. This represents 9.42% of its overall portfolio holdings.
Number of Shares
3,383,950
Previous 3,383,950
-0.0%
Holding current value
$230 Million
Previous $97.4 Million
61.42%
% of portfolio
9.42%
Previous 5.24%
Shares
6 transactions
Others Institutions Holding VRNA
# of Institutions
218Shares Held
70.5MCall Options Held
1.4MPut Options Held
299K-
Perceptive Advisors LLC New York, NY6.39MShares$434 Million9.9% of portfolio
-
Nea Management Company, LLC Timonium, MD5.58MShares$380 Million18.53% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.13MShares$213 Million2.79% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx3.13MShares$213 Million2.81% of portfolio
-
Wellington Management Group LLP Boston, MA3.03MShares$206 Million0.03% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $4.14B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...